On Thursday, the EMA (European Medicines Agency) approved the long-awaited treatment after initially blocking it in July, ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...

November is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

Researchers have revealed the role of enzyme TYK2 in the aggregation of tau proteins, which contributes to Alzheimer’s ...

“This can benefit us if we have hypochlorhydria or lack of stomach acid because it will acidify the stomach to help us digest ...

We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. Scientists say they ...

Essence may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Researchers have revealed how two neural circuits located in the brain's retrosplenial cortex are directly linked to spatial navigation and memory storage. This discovery could lead to more precise ...